Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 1
2020 1
2021 4
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
Arriola E, Bernabé R, Campelo RG, Biscuola M, Enguita AB, López-Ríos F, Martínez R, Mezquita L, Palanca S, Pareja MJ, Zugazagoitia J, Arrabal N, García JF, Carcedo D, de Álava E. Arriola E, et al. Among authors: carcedo d. JCO Precis Oncol. 2023 Mar;7:e2200546. doi: 10.1200/PO.22.00546. JCO Precis Oncol. 2023. PMID: 36862967 Free PMC article.
Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP).
Salas C, Martín-López J, Martínez-Pozo A, Hernández-Iglesias T, Carcedo D, Ruiz de Alda L, García JF, Rojo F. Salas C, et al. Among authors: carcedo d. J Clin Pathol. 2022 Mar;75(3):193-200. doi: 10.1136/jclinpath-2020-207280. Epub 2021 Mar 15. J Clin Pathol. 2022. PMID: 33722840 Free PMC article.
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.
de Alava E, Pareja MJ, Carcedo D, Arrabal N, García JF, Bernabé-Caro R. de Alava E, et al. Among authors: carcedo d. Expert Rev Pharmacoecon Outcomes Res. 2022 Sep;22(6):1033-1042. doi: 10.1080/14737167.2022.2078310. Epub 2022 May 25. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35593180 Free article.
Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study.
Aguiar C, Araujo F, Rubio-Mercade G, Carcedo D, Paz S, Castellano JM, Fuster V. Aguiar C, et al. Among authors: carcedo d. J Health Econ Outcomes Res. 2022 Nov 22;9(2):134-146. doi: 10.36469/001c.39768. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 36475278 Free PMC article.
16 results